Tender Notice for Metoclopramide 10 mg Tab,Metoprolol 1 mgobiliqueml 5 ml Inj,Metronidazole 1percent tube of 30gm,Met in Ajmer, RAJASTHAN
Progress
RAQuantity
9380
Categories
16
Indian Army has released a public tender for Metoclopramide 10 mg Tab, Metoprolol 1 mgobiliqueml 5 ml Inj, Metronidazole 1percent tube of 30gm, Metronidazole susp 200 mgobilique5ml bott of 60 ml, Micronised Progesterone 100mg Inj, Midazolam 5 mg 1 ml Inj, Mifepristone 50 mg Tab, Minocycline Hydrochloride 100 mg Cap, Mirtazapine 15 mg Tab, Morphine 15 mg 1 ml Inj, Moxifloxacin 400 mg Tab, Moxifloxacin HCl 0. 5percent with Dexamethasone 0. 1percent and Sodium phosphate 7. 8 BAK in IDP Preservative free drop tainer tech bott of 5ml Vegadexa, Multivitamin Inj IV 210 ml with minimum constituents having Thiamine B130mgobiliquemlPyridoxine B6 30mgobiliqueml and B12Cyanocobalamin300 mcgobiliqueml, Multivitamin with Zinc Syp Bott of 200ml, Multivitamin Multimineral with Grape Seed Extract Tablet Zincovit Capsule in Ajmer, RAJASTHAN. Quantity: 9380. Submission Deadline: 03-06-2025 10: 00: 00. Download documents and apply online.
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Item Category
Metoclopramide 10 mg Tab , Metoprolol 1 mgobiliqueml 5 ml Inj , Metronidazole 1percent tube of 30gm , Metronidazole susp 200 mgobilique5ml bott of 60 ml , Micronised Progesterone 100mg Inj , Midazolam 5 mg 1 ml Inj , Mifepristone 50 mg Tab , Minocycline Hydrochloride 100 mg Cap , Mirtazapine 15 mg Tab , Morphine 15 mg 1 ml Inj , Moxifloxacin 400 mg Tab , Moxifloxacin HCl 0.5percent with Dexamethasone 0.1percent and Sodium phosphate 7.8 BAK in IDP Preservative free drop tainer tech bott of 5ml Vegadexa , Multivitamin Inj IV 210 ml with minimum constituents having Thiamine B130mgobiliquemlPyridoxine B6 30mgobiliqueml and B12Cyanocobalamin300 mcgobiliqueml , Multivitamin with Zinc Syp Bott of 200ml , Multivitamin Multimineral with Grape Seed Extract Tablet Zincovit Capsule
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-7832684.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
15 Items Sign in to view GEM price trends Sign in for GEM prices
Metoclopramide 10 mg Tab
As per pdf
Metoprolol 1 mgobiliqueml 5 ml Inj
As per pdf
Metronidazole 1percent tube of 30gm
As per pdf
Metronidazole susp 200 mgobilique5ml bott of 60 ml
As per pdf
Micronised Progesterone 100mg Inj
As per pdf
Midazolam 5 mg 1 ml Inj
As per pdf
Mifepristone 50 mg Tab
As per pdf
Minocycline Hydrochloride 100 mg Cap
As per pdf
Mirtazapine 15 mg Tab
As per pdf
Morphine 15 mg 1 ml Inj
As per pdf
Moxifloxacin 400 mg Tab
As per pdf
Moxifloxacin HCl 0.5percent with Dexamethasone 0.1percent and Sodium phosphate 7.8 BAK in IDP Preservative free drop tainer tech bott of 5ml Vegadexa
As per pdf
Multivitamin Inj IV 210 ml with minimum constituents having Thiamine B130mgobiliquemlPyridoxine B6 30mgobiliqueml and B12Cyanocobalamin300 mcgobiliqueml
As per pdf
Multivitamin with Zinc Syp Bott of 200ml
As per pdf
Multivitamin Multimineral with Grape Seed Extract Tablet Zincovit Capsule
As per pdf
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Metoclopramide 10 mg Tab | As per pdf | 5,400 | no | shibanand-mallick | 30 | |
| 2 | Metoprolol 1 mgobiliqueml 5 ml Inj | As per pdf | 60 | amp vial | shibanand-mallick | 30 | |
| 3 | Metronidazole 1percent tube of 30gm | As per pdf | 30 | tube | shibanand-mallick | 30 | |
| 4 | Metronidazole susp 200 mgobilique5ml bott of 60 ml | As per pdf | 90 | bott | shibanand-mallick | 30 | |
| 5 | Micronised Progesterone 100mg Inj | As per pdf | 180 | amp vial | shibanand-mallick | 30 | |
| 6 | Midazolam 5 mg 1 ml Inj | As per pdf | 60 | amp vial | shibanand-mallick | 30 | |
| 7 | Mifepristone 50 mg Tab | As per pdf | 600 | no | shibanand-mallick | 30 | |
| 8 | Minocycline Hydrochloride 100 mg Cap | As per pdf | 360 | no | shibanand-mallick | 30 | |
| 9 | Mirtazapine 15 mg Tab | As per pdf | 600 | no | shibanand-mallick | 30 | |
| 10 | Morphine 15 mg 1 ml Inj | As per pdf | 240 | amp vial | shibanand-mallick | 30 | |
| 11 | Moxifloxacin 400 mg Tab | As per pdf | 360 | no | shibanand-mallick | 30 | |
| 12 | Moxifloxacin HCl 0.5percent with Dexamethasone 0.1percent and Sodium phosphate 7.8 BAK in IDP Preservative free drop tainer tech bott of 5ml Vegadexa | As per pdf | 100 | bott | shibanand-mallick | 30 | |
| 13 | Multivitamin Inj IV 210 ml with minimum constituents having Thiamine B130mgobiliquemlPyridoxine B6 30mgobiliqueml and B12Cyanocobalamin300 mcgobiliqueml | As per pdf | 100 | amp vial | shibanand-mallick | 30 | |
| 14 | Multivitamin with Zinc Syp Bott of 200ml | As per pdf | 300 | no | shibanand-mallick | 30 | |
| 15 | Multivitamin Multimineral with Grape Seed Extract Tablet Zincovit Capsule | As per pdf | 900 | no | shibanand-mallick | 30 |
Reverse Auction Schedule
Start
20-Jun-2025, 10:00 am
End
21-Jun-2025, 11:00 am
Duration: 25 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Technical Results
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 02-06-2025 16:16:51 | |
| 2 | ********** Under PMA | - | 02-06-2025 15:48:19 | |
| 3 | ********** Under PMA | - | 03-06-2025 00:22:32 | |
| 4 | ********** Under PMA | - | 02-06-2025 20:54:03 | |
| 5 | ********** Under PMA | - | 03-06-2025 05:56:02 | |
| 6 | ********** Under PMA | - | 03-06-2025 02:25:07 | |
| 7 | ********** Under PMA | - | 31-05-2025 12:51:21 | |
| 8 | ********** Under PMA | - | 03-06-2025 09:34:45 | |
| 9 | ********** Under PMA | - | 28-05-2025 13:17:56 | |
| 10 | ********** Under PMA | - | 31-05-2025 15:05:21 | |
| 11 | ********** Under PMA | - | 31-05-2025 17:42:49 | |
| 12 | ********** Under PMA | - | 02-06-2025 19:19:27 | |
| 13 | ********** Under PMA | - | 02-06-2025 19:31:29 |
Frequently Asked Questions
Key insights about RAJASTHAN tender market
What are the eligibility requirements for participating in the tender?
The eligibility requirements for this tender include that bidders must be registered entities and possess the necessary licenses to supply pharmaceutical products. They must demonstrate compliance with technical regulations and be capable of delivering the specified types and quantities of medications.
What technical specifications must the products meet?
All products submitted must comply with established technical specifications such as Good Manufacturing Practices (GMP). Bidders need to provide documentation that certifies their adherence to quality standards set by health authorities and regulations.
What is the procedure to register and submit documents for bidding?
To participate, bidders must register on the designated procurement platform. The registration process includes creating an account and verifying identity. Upon registration, bidders can submit documents in the accepted formats, ensuring all required documentation is complete and accurate.
What is the importance of Earnest Money Deposit (EMD) in the bidding process?
The Earnest Money Deposit (EMD) serves to secure a bidder's commitment to the tender. This monetary deposit is required to ensure that only serious bidders participate. Failure to provide the EMD may result in disqualification from the bidding process.
How are bids evaluated and selected for award?
The evaluation and selection process entails a rigorous assessment of submitted bids based on their conformity to technical specifications, financial robustness, and overall cost-effectiveness. Bids are scored and ranked according to these criteria, with notifications of results being communicated to bidders post-evaluation.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-7832684.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS